OP White Papers - random

  1. A Shift Towards Biofluorescent Particle Counters In Manufacturing 5/12/2025

    Sterility in injectable drug manufacturing is vital for patient safety and efficiency. Discover how biofluorescent particle counters revolutionize contamination control, regulatory compliance, and operational excellence in modern pharma.

  2. White Paper: Characterization Of Spray Dried Biologics 5/7/2025

    Discover how spray drying can transform the formulation of complex biologics by improving stability, delivery, and functionality, with insights into the critical techniques and strategies needed for successful development.

  3. Systematic Strategy To Reduce The Cost Of Goods Sold 3/26/2026

    Learn key ways to cut biologics manufacturing costs through smarter process design, material choices, and supply resilience — driving more efficient, reliable, and commercially sustainable production.

  4. The Importance Of Polymorph Screenings 5/6/2026

    Discover how systematic polymorph screening reduces development risk, safeguards product performance, and enables confident solid‑form selection across the drug development lifecycle.

  5. How The Accelerator™ Drug Development Model Enhances eNPV 2/25/2026

    Discover how an integrated CDMO and CRO model can accelerate development timelines, add up to $62.9 million in value, and help you maximize long-term pipeline success with a single, streamlined partner.

  6. Methods For Determining Equipment Capability Of Freeze-Dryers 10/16/2024

    Observe two experimental methods for determining choked flow: the minimum controllable pressure method and the choke point method.

  7. Fast Path To Market: Going From GMP1 To PPQ In Just 12 Months 4/30/2026

    Learn how focused optimization and coordinated execution helped overcome technical uncertainty and enable faster progression to market readiness.

  8. Leveraging Efficiency From CLD To Clinical Manufacturing Of mAbs 2/4/2026

    Discover how our efficient strategies can propel your mAb from discovery to clinical manufacturing in as little as 18 months.

  9. Cell Based Potency Assays: De-Risk Your Path With An Experienced CDMO 4/21/2026

    Thorough characterization is key to unlocking the potential of antibody-based therapeutics. Leveraging a CDMO's extensive capabilities and expertise can allow you to navigate the biopharmaceutical development landscape.

  10. The Effect Of Conventional Cooling Versus Controlled Ice Nucleation On Primary Drying Time 4/1/2026

    See how controlled ice nucleation shortens lyophilization cycles, supports higher drying temperatures, and reduces complexity for amorphous and mixed formulations without sacrificing quality.